PMC News Alert Pharmerica Corp (PMC) 20.76 12/25/2014 15:27:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pharmerica Corp (PMC) 20.76 $PMC

17.6% Return Seen to Date on SmarTrend PharMerica Call (PMC)
Comtex SmarTrend(R) - Wed Dec 24, 11:13AM CST
SmarTrend identified a Downtrend for PharMerica (NYSE MC) on November 11th, 2014 at $25.08. In approximately 1 month, PharMerica has returned 17.58% as of today's recent price of $20.67.
PMC: 20.76 (-0.13)

Shares of PMC Down 16.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 10, 9:31AM CST
SmarTrend identified a Downtrend for PharMerica (NYSE MC) on November 11th, 2014 at $25.08. In approximately 4 weeks, PharMerica has returned 16.51% as of today's recent price of $20.94.
PMC: 20.76 (-0.13)

Omnicare Rewards Shareholders with 10% Dividend Raise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 4:50PM CST
Healthcare services company, Omnicare (OCR), recently raised its quarterly dividend by 10% to 22 cents per share.
PMC: 20.76 (-0.13), OCR: 73.20 (+0.33), MCK: 209.79 (+0.58), CAH: 82.07 (+0.15)

PharMerica Has Returned 16.9% Since SmarTrend Recommendation (PMC)
Comtex SmarTrend(R) - Tue Dec 02, 5:24PM CST
SmarTrend identified a Downtrend for PharMerica (NYSE MC) on November 11th, 2014 at $25.08. In approximately 3 weeks, PharMerica has returned 16.91% as of today's recent price of $20.84.
PMC: 20.76 (-0.13)

Onco360 Selected by Pfizer as Limited Distribution Pharmacy Provider; Expands Onco360's Industry-Leading Portfolio to Nearly 40 Products
Business Wire - Mon Dec 01, 3:15PM CST
Onco360, one of the nation's largest independent providers of Oncology Pharmacy services, today announced that it has been selected as a limited distribution pharmacy network participant by Pfizer Inc. ("Pfizer" , and can immediately begin dispensing Bosulif(R) (bosutinib), Inlyta(R) (axitinib), Sutent(R) (sunitinib), and Xalkori(R) (crizotinib). With the addition of these four medications, Onco360's industry-leading oncology medication portfolio now comprises nearly 40 limited distribution products.
PMC: 20.76 (-0.13)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago PharMerica Is Down 14.2% (PMC)
Comtex SmarTrend(R) - Mon Nov 24, 7:19AM CST
18 days ago, on November 6th, 2014, PharMerica (NYSE MC) reported its earnings. Analysts, on average, expected earnings of $0.40 per share on sales of $440.4 million. PharMerica actually reported earnings of $0.45 per share on sales of $470.2 million, beating EPS estimates by $0.05 and beating revenue estimates by $29.8 million. Shares of PharMerica have slipped from $26.35 to $22.61, representing a loss of 14.2%, since the company reported earnings 18 days ago.
PMC: 20.76 (-0.13)

Post Earnings Update: PharMerica Has Sunk 8.8% Lower in Past Week (PMC)
Comtex SmarTrend(R) - Mon Nov 17, 8:34AM CST
When PharMerica (NYSE MC) reported earnings a week ago on November 6th, 2014, analysts, on average, expected the company to report earnings of $0.40 on sales of $440.4 million. PharMerica actually reported earnings of $0.45 per share on sales of $470.2 million, beating EPS estimates by $0.05 and beating revenue estimates by $29.8 million. Shares of PharMerica have slipped from $26.35 to $24.03, representing a loss of 8.8%, since the company reported earnings 11 days ago.
PMC: 20.76 (-0.13)

NYSE stocks posting largest percentage decreases
AP - Thu Nov 13, 12:28PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:
PMC: 20.76 (-0.13), RCAP: 11.23 (+0.26), W: 20.44 (-0.35), RICE: 22.41 (-0.33), RESI: 18.72 (+0.12), HP: 67.25 (-0.66), WAC: 16.73 (-0.15), TAHO: 13.31 (+0.56), ZEP: 15.59 (-0.01), CRK: 7.01 (-0.20), THO.TO: 15.46 (+0.63)

Pharmerica (PMC) Upgraded From Hold to Buy
at The Street - Wed Nov 12, 8:35AM CST
Pharmerica (PMC) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
PMC: 20.76 (-0.13)

PharMerica's (PMC) CEO Gregory Weishar on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:20PM CST

PMC: 20.76 (-0.13)

PharMerica (PMC) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 8:55AM CST

PMC: 20.76 (-0.13)

PharMerica beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 7:25AM CST

PMC: 20.76 (-0.13)

PharMerica Reports Third Quarter 2014 Results
Business Wire - Thu Nov 06, 7:21AM CST
--Successfully Executing Strategic and Operational Initiatives to Drive Long-Term Growth and Value Creation
PMC: 20.76 (-0.13)

PharMerica to Present at the Credit Suisse 2014 Healthcare Conference
Business Wire - Tue Oct 28, 9:20AM CDT
PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty home infusion, and oncology pharmacy services, today announced that David Froesel, Executive Vice President, Chief Financial Officer and Treasurer, will make a presentation regarding the Company at the Credit Suisse 2014 Healthcare Conference in Phoenix, Arizona, on Tuesday, November 11, 2014, at 1:30 p.m. Mountain Time (3:30 p.m. Eastern Time).
PMC: 20.76 (-0.13)

Omnicare Beats on Q3 Earnings and Sales, Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 11:40AM CDT
Omnicare Inc. (OCR) reported better-than-expected third quarter 2014 results.
PMC: 20.76 (-0.13), OCR: 73.20 (+0.33), CRL: 63.59 (+0.33), ICLR: 52.66 (+0.72)

Onco360 Appoints Paul Jardina as President and Chief Executive Officer
Business Wire - Mon Oct 27, 8:00AM CDT
Onco360, one of the nation's largest independent providers of oncology pharmacy services, today announced that Paul Jardina has been named President and Chief Executive Officer.
PMC: 20.76 (-0.13)

PharMerica Corporation Announces Third Quarter 2014 Earnings Call and Webcast
Business Wire - Mon Oct 13, 10:57AM CDT
PharMerica Corporation (NYSE MC) announced today that it will provide an online webcast of its third quarter 2014 earnings conference call on Thursday, November 6, 2014. The Company's results for the third quarter ended September 30, 2014 will be released before the open of the market on Thursday, November 6, 2014.
PMC: 20.76 (-0.13)

PharMerica closes Millennium Pharmacy Systems' acquisition, increasing its footprint in the Mid-Atlantic region
M2 - Mon Sep 29, 6:04AM CDT
Oncology pharmacy PharMerica (NYSE MC) revealed on Friday that it has completed the acquisition of Millennium Pharmacy Systems for an undisclosed value.
PMC: 20.76 (-0.13)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 25

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 142

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 115

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 81

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 177

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 98

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 115

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 83

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Specialty Chemicals Need Demand Before Capacity Bets

Updated Category News Views 96

Empty reactor space does not get filled because everybody suddenly loves reshoring. SOCMA's 2027 Contract Manufacturing Outlook makes that stubborn fact hard to dodge: nearly 70% of surveyed respondents expect North American manufacturing activity to rise over the next three years, yet 79.5% say stronger, more predictable customer demand is critical before future...

Continue Reading

Top 5 Most Recently Viewed Articles

New Terminal One Partners with Plaza Premium to Elevate Travel

Updated Category News Views 234

New Terminal One & Plaza Premium Group Collaboration The New Terminal One at JFK International Airport has joined forces with Plaza Premium Group (PPG), a leading name in airport hospitality, to create two state-of-the-art lounges. Together, they aim to transform the travel experience at this vital international hub, covering close to 14,000 square feet and promising...

Continue Reading
Market Update: S&P 500 Fluctuates After Holiday Trading

Updated Category News Views 337

S&P 500 Experiences Mixed Results in Light Trading The recent trading session saw the S&P 500 close on a flat note after a day of ups and downs, all in the backdrop of lower-than-usual trading volumes, a trend typical of the holiday breakout. As of the market close, the S&P 500 had dipped by 0.1%, while the NASDAQ Composite mirrored this decrease. In contrast, the Dow...

Continue Reading
Brand Engagement Network Expands Horizons with Cataneo Acquisition

Updated Category News Views 104

Brand Engagement Network Expands Strategic Capabilities Jackson, Wyo. – brand Engagement Network, Inc. (NASDAQ: BNAI) has recently made headlines by agreeing to acquire a German media technology powerhouse, Cataneo Gmbh. This acquisition not only highlights BEN's commitment to growth but also demonstrates its ambition to transform how brands use AI to engage with their...

Continue Reading
Metagenomi Showcases Advanced Adenine Base Editors for Gene Therapy

Updated Category News Views 195

Introducing Metagenomi's Innovative Adenine Base Editors Metagenomi has unveiled its cutting-edge Adenine Base Editors (ABEs) at a recent event, highlighting their impressive capabilities in genome editing. These novel tools achieved over 95% targetability in gene modification, demonstrating exceptional performance and efficiency. Key Highlights from the Presentation...

Continue Reading
Streamlining IT Procurement: SysAid Launches on AWS Marketplace

Updated Category News Views 49

SysAid Now Accessible via AWS Marketplace SysAid, a leading Enterprise and IT Service Management solution provider, has made an exciting announcement regarding its availability on AWS Marketplace. This curated digital catalog is designed to simplify the process of discovering, procuring, and deploying software solutions. With AWS Marketplace having over 290,000 active...

Continue Reading